1.
Elsevier ClinicalKey Clinical Overview
Treatment
Subsubsection Title: Procedures:
Subsubsection Title: Radical prostatectomy:
Subsubsection Title: General explanation:
Complete surgical removal of prostate
May be done by perineal or retropubic approach
Use of laparoscopy and robotic assistance has replaced open procedure in many centers
Length of hospital stay and transfusion requirements are lower in laparoscopic and robot-assisted procedures than in open procedures
Pelvic lymph node dissection may be done in conjunction if risk of nodal metastasis is calculated (by nomogram
Provides staging information but not consistently associated with improvement in metastasis-free or overall survival
Subsubsection Title: Indication:
Potentially curable disease in patients with life expectancy of 10 years or more
Subsubsection Title: Contraindications:
Poor functional status
Presence of comorbidities that pose unacceptable anesthesia risk
Locally invasive disease (eg, involvement of adjacent organs)
Subsubsection Title: Complications:
Erectile dysfunction
Urinary incontinence
Subsubsection Title: External beam radiation therapy:
Subsubsection Title: General explanation:
Use of image-guided external beam radiation therapy to destroy malignancy
Rapidly evolving newer techniques may reduce collateral tissue damage and duration of treatment
Subsubsection Title: Indication:
Potentially curable disease
Palliative therapy for bone metastases
Subsubsection Title: Contraindications:
Previous radiation therapy to pelvic area
Active inflammatory disease of rectum (eg, ulcerative colitis)
Permanent indwelling urinary catheter
Subsubsection Title: Complications:
Urinary incontinence
Erectile dysfunction
Lower urinary tract symptoms (eg, urgency, frequency, hematuria)
Rectal bleeding and diarrhea; latter may become chronic
Subsubsection Title: Brachytherapy:
Subsubsection Title: General explanation:
Treatment
May be offered to the following groups:
Very-low-risk patients with life expectancy of 20 years or more
Low-risk patients with life expectancy of 10 years or more
Treatment options
Radical prostatectomy (perineal, retropubic, laparoscopic, or robot-assisted)
May include pelvic lymph node dissection in patients with 2% or greater chance of lymph node involvement
Risk is assessed by nomogram
Most common adverse effects
Stress urinary incontinence
Erectile dysfunction
Lymphedema and/or lymphocele may occur if lymphadenectomy is performed
Systematic review of laparoscopic, robot-assisted, and open prostatectomy found no high-quality evidence comparing with long-term oncologic outcomes
Overall complication rate and urinary and sexual quality of life were similar
Length of hospital stay and transfusion requirements were greater in open procedures
Definitive radiation therapy
External beam radiation therapy
Several techniques are available: intensity modulated, stereotactic, or hypofractionated
Hypofractionation entails delivery of higher doses per fraction (ie, session), thus shortening duration needed to administer total dose; it may be offered to patients in lower-risk categories who have opted for treatment with selected external beam radiation therapy
Associated with small increased risk of early gastrointestinal adverse effects, but long-term toxicity appears similar to that in conventional external beam radiation therapy
Long-term efficacy data are not yet available, but 5-year outcomes for hypofractionation appear similar to those for conventional radiation therapy
May be an appropriate choice in the following additional groups:
Select patients with unfavorable intermediate-risk disease and life expectancy of less than 10 years
Select patients with high- or very-high-risk disease and life expectancy of 5 years or less
Prostate cancer exhibits extensive clinical heterogeneity, and some men may be treated aggressively for cancers that will never cause clinical symptoms. Treatment decisions are based not only on risk stratification and the stage of disease but also on the side effects of treatment (Table 186-3).,Localized DiseaseA number of treatment options are available for patients who have localized prostate cancer (Table 186-3).Watchful Waiting and Active SurveillanceObservation (watchful waiting) is an option for men who have competing causes of death that are likely to shorten life-expectancy to less than 10 years.Another strategy is active surveillance, which includes PSA testing every 6 months, a digital rectal examination once a year, repeat prostate biopsies potentially every 12 months, and consideration of MRI spectroscopy.,Ki-67 is a marker of proliferation, and high staining for Ki-67 and/or loss of PTEN may identify patients who may require more aggressive treatment.Curative TherapyBoth radical prostatectomy and radiation therapy can achieve a high cure rate for early disease. The preferred option should consider the patient’s wishes, experience, and expectations. Referral to the appropriate specialist or team is highly encouraged to provide a balanced explanation of the impacts of each option on bowel, bladder, and sexual function, as well as other systemic side effects.Radical prostatectomy is an option for patients who have clinically localized disease and a life expectancy of more than 10 years.Laparoscopic and robot-assisted radical prostatectomy are commonly performed rather than open radical prostatectomy to reduce the length of hospital stay as well as blood loss, surgical complications, urinary incontinence, and erectile dysfunction.In patients in whom the probability of nodal involvement is high, a pelvic lymph node dissection should be performed, typically at the time of prostatectomy.